Connection

Michael Ostrowski to Recombinant Proteins

This is a "connection" page, showing publications Michael Ostrowski has written about Recombinant Proteins.
Connection Strength

0.174
  1. Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter. J Biol Chem. 2003 May 16; 278(20):17876-84.
    View in: PubMed
    Score: 0.046
  2. The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling. Nucleic Acids Res. 1996 May 15; 24(10):1971-8.
    View in: PubMed
    Score: 0.029
  3. Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes. J Exp Med. 1994 Dec 01; 180(6):2309-19.
    View in: PubMed
    Score: 0.026
  4. Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma. Mol Ther. 2013 Aug; 21(8):1517-25.
    View in: PubMed
    Score: 0.023
  5. SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility. J Clin Endocrinol Metab. 2013 May; 98(5):E973-80.
    View in: PubMed
    Score: 0.023
  6. The carboxy-terminal catalytic domain of the GTPase-activating protein inhibits nuclear signal transduction and morphological transformation mediated by the CSF-1 receptor. Genes Dev. 1991 Oct; 5(10):1777-85.
    View in: PubMed
    Score: 0.021
  7. Cyclic AMP-dependent activation of Rap1b. J Biol Chem. 1995 May 05; 270(18):10373-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.